On a per-share basis, the Tustin, California-based company said it had a loss of 8 cents.
The pharmaceutical posted revenue of $5.7 million in the period.
In the final minutes of trading on Thursday, the company’s shares hit $1.45. A year ago, they were trading at $2.33.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PPHM at http://www.zacks.com/ap/PPHM